Danaher Corporation Stock NYSE
Stocks
DHR PRB
US2358514097
Advanced Medical Equipment & Technology
| Market Cap | 135B 118B 110B 101B 190B 12,964B 193B 1,306B 510B 6,374B 505B 494B 22,037B | P/E 2026 * |
32x | P/E 2027 * | 25.6x |
|---|---|---|---|---|---|
| Enterprise Value | 155B 136B 126B 116B 218B 14,900B 221B 1,501B 586B 7,325B 581B 568B 25,327B | EV / Sales 2026 * |
5.88x | EV / Sales 2027 * | 5.25x |
| Free-Float |
70.58% | Yield 2026 * |
0.77% | Yield 2027 * | 0.82% |
Last Transcript: Danaher Corporation
| 1 day | -0.78% |
| Manager | Title | Age | Since |
|---|---|---|---|
Rainer Blair
CEO | Chief Executive Officer | 62 | 01/09/2020 |
Matthew Gugino
DFI | Director of Finance/CFO | - | 28/02/2026 |
Steven Dee
CTO | Chief Tech/Sci/R&D Officer | - | 25/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Alan Spoon
BRD | Director/Board Member | 74 | 01/07/1999 |
Steven Rales
CHM | Chairman | 74 | 01/01/1984 |
Mitchell Rales
BRD | Director/Board Member | 69 | 01/01/1984 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.78% | +1.02% | - | - | 135B | |
| -0.71% | +6.72% | +19.63% | -0.57% | 211B | |
| +1.65% | -2.29% | -30.93% | +4.31% | 119B | |
| +1.54% | +0.50% | -58.34% | -15.18% | 65.77B | |
| -1.42% | -3.62% | +9.01% | -9.60% | 47.58B | |
| +3.03% | -0.17% | -26.81% | -31.58% | 44.44B | |
| -0.84% | +5.41% | +15.14% | +8.50% | 39.14B | |
| -2.02% | +1.54% | +25.53% | +30.56% | 36.79B | |
| -1.41% | +3.99% | +80.31% | +3.20% | 29.37B | |
| +1.76% | -1.87% | -28.60% | -10.49% | 28.17B | |
| Average | +0.08% | +0.55% | +0.55% | -2.32% | 69.07B | |
| Weighted average by Cap. | +0.01% | +1.50% | -1.70% | -1.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26.3B 23.1B 21.49B 19.72B 37.04B 2,533B 37.61B 255B 99.68B 1,245B 98.75B 96.62B 4,306B | 28.36B 24.91B 23.16B 21.26B 39.94B 2,731B 40.55B 275B 107B 1,343B 106B 104B 4,642B |
| Net income | 4.22B 3.71B 3.45B 3.16B 5.95B 407B 6.04B 40.95B 16B 200B 15.85B 15.51B 691B | 5.38B 4.73B 4.4B 4.03B 7.58B 518B 7.7B 52.2B 20.39B 255B 20.2B 19.77B 881B |
| Net Debt | 20.1B 17.65B 16.42B 15.06B 28.3B 1,935B 28.74B 195B 76.16B 952B 75.44B 73.82B 3,290B | 14.14B 12.42B 11.55B 10.59B 19.91B 1,361B 20.21B 137B 53.56B 669B 53.06B 51.92B 2,314B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
